METHODS OF TREATMENT OF GLAUCOMA AND OTHER CONDITIONS MEDIATED BY NOS-2 EXPRESSION VIA INHIBITION OF THE EGFR PATHWAY

Details for Australian Patent Application No. 2003241398 (hide)

Owner WASHINGTON UNIVERSITY

Inventors NEUFELD, Arthur, H.; LIU, Bin

Pub. Number AU-A-2003241398

PCT Number PCT/US03/14484

PCT Pub. Number WO2003/092693

Priority 60/378,254 06.05.02 US

Filing date 6 May 2003

Wipo publication date 17 November 2003

International Classifications

A61K 031/47 - Quinolines

A61K 031/60 - Salicylic acid

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/378,254 06.05.02 US

8 January 2004 Application Open to Public Inspection

  Published as AU-A-2003241398

10 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003241399-Cortical and cancellous allograft cervical fusion block implant

2003241397-FIELD SEQUENTIAL COLOR EFFICIENCY